Inventor
Alan Michael Easton
Inventor
Maryland Heights, MO, US
Overview
Patents· 32 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides30%
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests11%
C12NMicroorganisms or enzymes9%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture2%
PatentTitleYear
7,238,507'Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase'20077,091,319'IL-3 variant hematopoiesis fusion protein'20067,033,807'Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase'20066,479,261'Methods of using interleukin-3 (IL-3) mutant polypeptides for ex-vivo expansion of hematopoietic stem cells'20026,458,931'Interleukin-3 (IL-3) multiple mutation polypeptides'20026,440,407'Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 (IL-3) multiple mutation polypeptides'20026,436,387'Methods of ex-vivo expansion of hematopoietic cells using multivariant IL-3 hematopoiesis chimera proteins'20026,413,509'Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 mutant polypeptides with other hematopoietic growth factors'20026,403,076'Compositions for increasing hematopoiesis with interleukin-3 mutants'20026,379,662'Co-administration of interleukin-3 mutant polypeptides with CSF\'s for multi-lineage hematopoietic cell production'20026,361,976'Co-administration of interleukin-3 mutant polypeptides with CSF\'S for multi-lineage hematopoietic cell production'20026,361,977'Methods of using multivariant IL-3 hematopoiesis fusion protein'20026,153,183'Co-administration of interleukin-3 mutant polypeptides with CSF\'s or cytokines for multi-lineage hematopoietic cell production'20006,132,991'Human interleukin-3 (IL-3) variant fusion proteins'20006,093,395'Co-administration of interleukin-3 mutant polypeptides with CSF\'s for multi-lineage hematopoietic cell production'20006,074,639'Ex vivo expansion of hematopoietic cells using interleukin-3 (IL-3) variant fusion proteins'20006,060,047'Co-administration of interleukin-3 mutant polypeptides with CSF\'s for multi-lineage hematopoietic cell production'20006,057,133'Multivariant human IL-3 fusion proteins and their recombinant production'20006,051,217'Therapeutic uses of interleukin-3 (IL-3) multiple mutation polypeptides'20006,030,812'Fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors'20006,022,535'Treatment of hematopoietic disorders with fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors'20006,017,523'Therapeutic methods employing mutant human interleukin-3 (IL-3) polypeptides'20005,997,860'Ex-vivo expansion of stem cells using combinations of interleukin-3 (IL-3) variants and other cytokines'19995,997,857'Co-administration of interleukin-3 mutants with colony stimulating factors'19995,858,347'Therapeutic methods using fusion proteins between interleukin-3 (IL-3) variants and other hematopoietic factors'19995,817,486'Recombinant human interleukin-3 (IL-3) multiple mutation polypeptides'19985,772,992'Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors'19985,738,849'Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them'19985,677,149'Interleukin-3 (IL-3) mutant polypeptides and their recombinant production'19975,604,116'Interleukin-3 (IL-3) multiple mutation polypeptides, recombinant production of the same, and corresponding therapeutic methods'19975,543,141'Therapeutic methods using interleukin-3 (IL-3) human/murine hybrid polypeptides'19965,501,962'Interleuken-3 (IL-3) human/murine hybrid polypeptides and recombinant production of the same'1996Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1996–2002Patents assigned to SEARLE & CO (22)· patent assignee history
1996–2007Based in Maryland Heights, MO, US· patent location history
2002–2007Patents assigned to PHARMACIA CORP (3)· patent assignee history
2006Patents assigned to ABRAMS MARK ALLEN (1)· patent assignee history
2006Patents assigned to BAUER S CHRISTOPHER (1)· patent assignee history
2006Patents assigned to BRAFORD-GOLDBERG SARAH RUTH (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SEARLE & CO | 22 | 1996–2002 |
| PHARMACIA CORP | 3 | 2002–2007 |
| ABRAMS MARK ALLEN | 1 | 2006 |
| BAUER S CHRISTOPHER | 1 | 2006 |
| BRAFORD-GOLDBERG SARAH RUTH | 1 | 2006 |
Locations
| Location | Patents | Span |
|---|---|---|
| Maryland Heights, MO, US | 32 | 1996–2007 |